Clinical trial
Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung…
NCT00264134 · Kentuckiana Cancer Institute, Other · Terminated
Key facts
| NCT number | NCT00264134 |
|---|---|
| Title | Docetaxel, Irinotecan, and Carboplatin in Extensive Stage Non-Small Cell Lung Cancer |
| Official title | A Phase I/II Trial: Docetaxel, Irinotecan, and Carboplatin in the Treatment of Extensive Stage Small Cell Lung Carcinoma |
| Lead sponsor | Kentuckiana Cancer Institute, Other |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Non-small Cell Lung Cancer, Extensive Stage Unresectable |
| Intervention type | Drug |
| Interventions | Docetaxel, Irinotecan, Carboplatin |
| Enrollment | 40 |
| Start date | Jun 1, 2003 |
| Completion | Oct 1, 2005 |
| First posted | Dec 12, 2005 |
| Last update posted | Jan 20, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: